[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Cell and Gene Therapy CRO Service Supply, Demand and Key Producers, 2023-2029

December 2023 | 113 pages | ID: G401327A19AFEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Cell and Gene Therapy CRO Service market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Cell and Gene Therapy CRO (Contract Research Organization) Service refers to a service offered by a third-party organization that specializes in providing research and development support to companies involved in cell and gene therapy. This service may include cell line development, preclinical testing, clinical trial management, regulatory services, and product manufacturing to facilitate the development and commercialization of cell and gene therapies.

This report studies the global Cell and Gene Therapy CRO Service demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy CRO Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy CRO Service that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Cell and Gene Therapy CRO Service total market, 2018-2029, (USD Million)

Global Cell and Gene Therapy CRO Service total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Cell and Gene Therapy CRO Service total market, key domestic companies and share, (USD Million)

Global Cell and Gene Therapy CRO Service revenue by player and market share 2018-2023, (USD Million)

Global Cell and Gene Therapy CRO Service total market by Type, CAGR, 2018-2029, (USD Million)

Global Cell and Gene Therapy CRO Service total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Cell and Gene Therapy CRO Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PPD, Medpace, Labcorp, Veristat, Charles River Laboratories, Premier Research, Catalent, IQVIA and Vial, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy CRO Service market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cell and Gene Therapy CRO Service Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Cell and Gene Therapy CRO Service Market, Segmentation by Type
  • Preclinical CRO
  • Clinical Stage CRO
  • Others
Global Cell and Gene Therapy CRO Service Market, Segmentation by Application
  • Hospital
  • Research Institute
  • Others
Companies Profiled:
  • PPD
  • Medpace
  • Labcorp
  • Veristat
  • Charles River Laboratories
  • Premier Research
  • Catalent
  • IQVIA
  • Vial
  • Noble Life Sciences
  • Ergomed
Key Questions Answered

1. How big is the global Cell and Gene Therapy CRO Service market?

2. What is the demand of the global Cell and Gene Therapy CRO Service market?

3. What is the year over year growth of the global Cell and Gene Therapy CRO Service market?

4. What is the total value of the global Cell and Gene Therapy CRO Service market?

5. Who are the major players in the global Cell and Gene Therapy CRO Service market?
1 SUPPLY SUMMARY

1.1 Cell and Gene Therapy CRO Service Introduction
1.2 World Cell and Gene Therapy CRO Service Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cell and Gene Therapy CRO Service Total Market by Region (by Headquarter Location)
  1.3.1 World Cell and Gene Therapy CRO Service Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Cell and Gene Therapy CRO Service Market Size (2018-2029)
  1.3.3 China Cell and Gene Therapy CRO Service Market Size (2018-2029)
  1.3.4 Europe Cell and Gene Therapy CRO Service Market Size (2018-2029)
  1.3.5 Japan Cell and Gene Therapy CRO Service Market Size (2018-2029)
  1.3.6 South Korea Cell and Gene Therapy CRO Service Market Size (2018-2029)
  1.3.7 ASEAN Cell and Gene Therapy CRO Service Market Size (2018-2029)
  1.3.8 India Cell and Gene Therapy CRO Service Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Cell and Gene Therapy CRO Service Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Cell and Gene Therapy CRO Service Major Market Trends

2 DEMAND SUMMARY

2.1 World Cell and Gene Therapy CRO Service Consumption Value (2018-2029)
2.2 World Cell and Gene Therapy CRO Service Consumption Value by Region
  2.2.1 World Cell and Gene Therapy CRO Service Consumption Value by Region (2018-2023)
  2.2.2 World Cell and Gene Therapy CRO Service Consumption Value Forecast by Region (2024-2029)
2.3 United States Cell and Gene Therapy CRO Service Consumption Value (2018-2029)
2.4 China Cell and Gene Therapy CRO Service Consumption Value (2018-2029)
2.5 Europe Cell and Gene Therapy CRO Service Consumption Value (2018-2029)
2.6 Japan Cell and Gene Therapy CRO Service Consumption Value (2018-2029)
2.7 South Korea Cell and Gene Therapy CRO Service Consumption Value (2018-2029)
2.8 ASEAN Cell and Gene Therapy CRO Service Consumption Value (2018-2029)
2.9 India Cell and Gene Therapy CRO Service Consumption Value (2018-2029)

3 WORLD CELL AND GENE THERAPY CRO SERVICE COMPANIES COMPETITIVE ANALYSIS

3.1 World Cell and Gene Therapy CRO Service Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Cell and Gene Therapy CRO Service Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy CRO Service in 2022
  3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy CRO Service in 2022
3.3 Cell and Gene Therapy CRO Service Company Evaluation Quadrant
3.4 Cell and Gene Therapy CRO Service Market: Overall Company Footprint Analysis
  3.4.1 Cell and Gene Therapy CRO Service Market: Region Footprint
  3.4.2 Cell and Gene Therapy CRO Service Market: Company Product Type Footprint
  3.4.3 Cell and Gene Therapy CRO Service Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Cell and Gene Therapy CRO Service Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Cell and Gene Therapy CRO Service Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Cell and Gene Therapy CRO Service Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy CRO Service Consumption Value Comparison
  4.2.1 United States VS China: Cell and Gene Therapy CRO Service Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Cell and Gene Therapy CRO Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cell and Gene Therapy CRO Service Companies and Market Share, 2018-2023
  4.3.1 United States Based Cell and Gene Therapy CRO Service Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Cell and Gene Therapy CRO Service Revenue, (2018-2023)
4.4 China Based Companies Cell and Gene Therapy CRO Service Revenue and Market Share, 2018-2023
  4.4.1 China Based Cell and Gene Therapy CRO Service Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Cell and Gene Therapy CRO Service Revenue, (2018-2023)
4.5 Rest of World Based Cell and Gene Therapy CRO Service Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Cell and Gene Therapy CRO Service Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Cell and Gene Therapy CRO Service Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Cell and Gene Therapy CRO Service Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Preclinical CRO
  5.2.2 Clinical Stage CRO
  5.2.3 Others
5.3 Market Segment by Type
  5.3.1 World Cell and Gene Therapy CRO Service Market Size by Type (2018-2023)
  5.3.2 World Cell and Gene Therapy CRO Service Market Size by Type (2024-2029)
  5.3.3 World Cell and Gene Therapy CRO Service Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Cell and Gene Therapy CRO Service Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Research Institute
  6.2.3 Others
6.3 Market Segment by Application
  6.3.1 World Cell and Gene Therapy CRO Service Market Size by Application (2018-2023)
  6.3.2 World Cell and Gene Therapy CRO Service Market Size by Application (2024-2029)
  6.3.3 World Cell and Gene Therapy CRO Service Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 PPD
  7.1.1 PPD Details
  7.1.2 PPD Major Business
  7.1.3 PPD Cell and Gene Therapy CRO Service Product and Services
  7.1.4 PPD Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 PPD Recent Developments/Updates
  7.1.6 PPD Competitive Strengths & Weaknesses
7.2 Medpace
  7.2.1 Medpace Details
  7.2.2 Medpace Major Business
  7.2.3 Medpace Cell and Gene Therapy CRO Service Product and Services
  7.2.4 Medpace Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Medpace Recent Developments/Updates
  7.2.6 Medpace Competitive Strengths & Weaknesses
7.3 Labcorp
  7.3.1 Labcorp Details
  7.3.2 Labcorp Major Business
  7.3.3 Labcorp Cell and Gene Therapy CRO Service Product and Services
  7.3.4 Labcorp Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Labcorp Recent Developments/Updates
  7.3.6 Labcorp Competitive Strengths & Weaknesses
7.4 Veristat
  7.4.1 Veristat Details
  7.4.2 Veristat Major Business
  7.4.3 Veristat Cell and Gene Therapy CRO Service Product and Services
  7.4.4 Veristat Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Veristat Recent Developments/Updates
  7.4.6 Veristat Competitive Strengths & Weaknesses
7.5 Charles River Laboratories
  7.5.1 Charles River Laboratories Details
  7.5.2 Charles River Laboratories Major Business
  7.5.3 Charles River Laboratories Cell and Gene Therapy CRO Service Product and Services
  7.5.4 Charles River Laboratories Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Charles River Laboratories Recent Developments/Updates
  7.5.6 Charles River Laboratories Competitive Strengths & Weaknesses
7.6 Premier Research
  7.6.1 Premier Research Details
  7.6.2 Premier Research Major Business
  7.6.3 Premier Research Cell and Gene Therapy CRO Service Product and Services
  7.6.4 Premier Research Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Premier Research Recent Developments/Updates
  7.6.6 Premier Research Competitive Strengths & Weaknesses
7.7 Catalent
  7.7.1 Catalent Details
  7.7.2 Catalent Major Business
  7.7.3 Catalent Cell and Gene Therapy CRO Service Product and Services
  7.7.4 Catalent Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Catalent Recent Developments/Updates
  7.7.6 Catalent Competitive Strengths & Weaknesses
7.8 IQVIA
  7.8.1 IQVIA Details
  7.8.2 IQVIA Major Business
  7.8.3 IQVIA Cell and Gene Therapy CRO Service Product and Services
  7.8.4 IQVIA Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 IQVIA Recent Developments/Updates
  7.8.6 IQVIA Competitive Strengths & Weaknesses
7.9 Vial
  7.9.1 Vial Details
  7.9.2 Vial Major Business
  7.9.3 Vial Cell and Gene Therapy CRO Service Product and Services
  7.9.4 Vial Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Vial Recent Developments/Updates
  7.9.6 Vial Competitive Strengths & Weaknesses
7.10 Noble Life Sciences
  7.10.1 Noble Life Sciences Details
  7.10.2 Noble Life Sciences Major Business
  7.10.3 Noble Life Sciences Cell and Gene Therapy CRO Service Product and Services
  7.10.4 Noble Life Sciences Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Noble Life Sciences Recent Developments/Updates
  7.10.6 Noble Life Sciences Competitive Strengths & Weaknesses
7.11 Ergomed
  7.11.1 Ergomed Details
  7.11.2 Ergomed Major Business
  7.11.3 Ergomed Cell and Gene Therapy CRO Service Product and Services
  7.11.4 Ergomed Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Ergomed Recent Developments/Updates
  7.11.6 Ergomed Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Cell and Gene Therapy CRO Service Industry Chain
8.2 Cell and Gene Therapy CRO Service Upstream Analysis
8.3 Cell and Gene Therapy CRO Service Midstream Analysis
8.4 Cell and Gene Therapy CRO Service Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Cell and Gene Therapy CRO Service Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cell and Gene Therapy CRO Service Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cell and Gene Therapy CRO Service Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cell and Gene Therapy CRO Service Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cell and Gene Therapy CRO Service Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell and Gene Therapy CRO Service Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cell and Gene Therapy CRO Service Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cell and Gene Therapy CRO Service Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cell and Gene Therapy CRO Service Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cell and Gene Therapy CRO Service Players in 2022
Table 12. World Cell and Gene Therapy CRO Service Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cell and Gene Therapy CRO Service Company Evaluation Quadrant
Table 14. Head Office of Key Cell and Gene Therapy CRO Service Player
Table 15. Cell and Gene Therapy CRO Service Market: Company Product Type Footprint
Table 16. Cell and Gene Therapy CRO Service Market: Company Product Application Footprint
Table 17. Cell and Gene Therapy CRO Service Mergers & Acquisitions Activity
Table 18. United States VS China Cell and Gene Therapy CRO Service Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cell and Gene Therapy CRO Service Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cell and Gene Therapy CRO Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell and Gene Therapy CRO Service Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cell and Gene Therapy CRO Service Revenue Market Share (2018-2023)
Table 23. China Based Cell and Gene Therapy CRO Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell and Gene Therapy CRO Service Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cell and Gene Therapy CRO Service Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cell and Gene Therapy CRO Service Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cell and Gene Therapy CRO Service Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cell and Gene Therapy CRO Service Revenue Market Share (2018-2023)
Table 29. World Cell and Gene Therapy CRO Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cell and Gene Therapy CRO Service Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cell and Gene Therapy CRO Service Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cell and Gene Therapy CRO Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cell and Gene Therapy CRO Service Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cell and Gene Therapy CRO Service Market Size by Application (2024-2029) & (USD Million)
Table 35. PPD Basic Information, Area Served and Competitors
Table 36. PPD Major Business
Table 37. PPD Cell and Gene Therapy CRO Service Product and Services
Table 38. PPD Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. PPD Recent Developments/Updates
Table 40. PPD Competitive Strengths & Weaknesses
Table 41. Medpace Basic Information, Area Served and Competitors
Table 42. Medpace Major Business
Table 43. Medpace Cell and Gene Therapy CRO Service Product and Services
Table 44. Medpace Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Medpace Recent Developments/Updates
Table 46. Medpace Competitive Strengths & Weaknesses
Table 47. Labcorp Basic Information, Area Served and Competitors
Table 48. Labcorp Major Business
Table 49. Labcorp Cell and Gene Therapy CRO Service Product and Services
Table 50. Labcorp Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Labcorp Recent Developments/Updates
Table 52. Labcorp Competitive Strengths & Weaknesses
Table 53. Veristat Basic Information, Area Served and Competitors
Table 54. Veristat Major Business
Table 55. Veristat Cell and Gene Therapy CRO Service Product and Services
Table 56. Veristat Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Veristat Recent Developments/Updates
Table 58. Veristat Competitive Strengths & Weaknesses
Table 59. Charles River Laboratories Basic Information, Area Served and Competitors
Table 60. Charles River Laboratories Major Business
Table 61. Charles River Laboratories Cell and Gene Therapy CRO Service Product and Services
Table 62. Charles River Laboratories Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Charles River Laboratories Recent Developments/Updates
Table 64. Charles River Laboratories Competitive Strengths & Weaknesses
Table 65. Premier Research Basic Information, Area Served and Competitors
Table 66. Premier Research Major Business
Table 67. Premier Research Cell and Gene Therapy CRO Service Product and Services
Table 68. Premier Research Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Premier Research Recent Developments/Updates
Table 70. Premier Research Competitive Strengths & Weaknesses
Table 71. Catalent Basic Information, Area Served and Competitors
Table 72. Catalent Major Business
Table 73. Catalent Cell and Gene Therapy CRO Service Product and Services
Table 74. Catalent Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Catalent Recent Developments/Updates
Table 76. Catalent Competitive Strengths & Weaknesses
Table 77. IQVIA Basic Information, Area Served and Competitors
Table 78. IQVIA Major Business
Table 79. IQVIA Cell and Gene Therapy CRO Service Product and Services
Table 80. IQVIA Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. IQVIA Recent Developments/Updates
Table 82. IQVIA Competitive Strengths & Weaknesses
Table 83. Vial Basic Information, Area Served and Competitors
Table 84. Vial Major Business
Table 85. Vial Cell and Gene Therapy CRO Service Product and Services
Table 86. Vial Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Vial Recent Developments/Updates
Table 88. Vial Competitive Strengths & Weaknesses
Table 89. Noble Life Sciences Basic Information, Area Served and Competitors
Table 90. Noble Life Sciences Major Business
Table 91. Noble Life Sciences Cell and Gene Therapy CRO Service Product and Services
Table 92. Noble Life Sciences Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Noble Life Sciences Recent Developments/Updates
Table 94. Ergomed Basic Information, Area Served and Competitors
Table 95. Ergomed Major Business
Table 96. Ergomed Cell and Gene Therapy CRO Service Product and Services
Table 97. Ergomed Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Cell and Gene Therapy CRO Service Upstream (Raw Materials)
Table 99. Cell and Gene Therapy CRO Service Typical Customers

LIST OF FIGURE

Figure 1. Cell and Gene Therapy CRO Service Picture
Figure 2. World Cell and Gene Therapy CRO Service Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cell and Gene Therapy CRO Service Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cell and Gene Therapy CRO Service Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cell and Gene Therapy CRO Service Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cell and Gene Therapy CRO Service Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cell and Gene Therapy CRO Service Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cell and Gene Therapy CRO Service Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cell and Gene Therapy CRO Service Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cell and Gene Therapy CRO Service Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cell and Gene Therapy CRO Service Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cell and Gene Therapy CRO Service Revenue (2018-2029) & (USD Million)
Figure 13. Cell and Gene Therapy CRO Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell and Gene Therapy CRO Service Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cell and Gene Therapy CRO Service Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cell and Gene Therapy CRO Service Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cell and Gene Therapy CRO Service Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell and Gene Therapy CRO Service Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cell and Gene Therapy CRO Service Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cell and Gene Therapy CRO Service Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cell and Gene Therapy CRO Service Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cell and Gene Therapy CRO Service Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cell and Gene Therapy CRO Service by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy CRO Service Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy CRO Service Markets in 2022
Figure 27. United States VS China: Cell and Gene Therapy CRO Service Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cell and Gene Therapy CRO Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cell and Gene Therapy CRO Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cell and Gene Therapy CRO Service Market Size Market Share by Type in 2022
Figure 31. Preclinical CRO
Figure 32. Clinical Stage CRO
Figure 33. Others
Figure 34. World Cell and Gene Therapy CRO Service Market Size Market Share by Type (2018-2029)
Figure 35. World Cell and Gene Therapy CRO Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Cell and Gene Therapy CRO Service Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Research Institute
Figure 39. Others
Figure 40. Cell and Gene Therapy CRO Service Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source


More Publications